NIH-funded research NIH-funded research

A network for sharing data and resources in immuno-oncology

Official title: Immuno-Oncology Translation Network: Data Management and Resource-Sharing Center at RPCI

Funded at Roswell Park Cancer Institute Corp · NIH-10872397 · Data updated 2026-11-12

This study is all about finding better ways to use immune therapies to fight cancer by working together to understand why some cancers resist treatment and exploring new combinations of therapies, all aimed at helping adults with cancer feel better and live longer.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionRoswell Park Cancer Institute Corp
NIH-funded
Lab location1 site (Buffalo, United States)
Project startJuly 1, 2023
Project endAugust 31, 2025
Funding year2023
Award (this year)$433,750
NIH project number3U24CA232979-01S9
Project IDNIH-10872397 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults diagnosed with cancer who may benefit from innovative immunotherapy approaches.

Less likely to help

Patients with non-malignant conditions or those who are not adults may not receive benefits from this research.

What this research studies

This research focuses on enhancing the clinical use of immuno-oncology strategies by collaborating to understand cancer resistance mechanisms, discover new immune targets, and evaluate combination therapies. A multidisciplinary team will manage data collection and analysis to support various immuno-oncology projects aimed at treating and preventing cancers in adults. The initiative will streamline access to analytical expertise and foster collaboration among researchers to improve cancer treatment outcomes.

Why it matters

Potential benefit: If successful, this research could lead to more effective immunotherapy treatments for cancer patients.

How similar studies have gone: Previous research in immuno-oncology has shown promising results, indicating that collaborative approaches can lead to significant advancements in cancer treatment.

Where this research is happening

  • Roswell Park Cancer Institute Corp
    Buffalo, United States
    Active

Researchers

  • Principal investigator: Hutson, Alan David — Roswell Park Cancer Institute Corp
  • Study coordinator: Hutson, Alan David

Related research

Other NIH-funded projects on the same topics.

  • A network for sharing data and resources in immuno-oncology.

    This study is all about bringing together experts to find better ways to treat cancer by understanding why some treatments don’t work and discovering new targets for the immune system, which could lead to more personalized and effective therapies for adults.

    NIH research Roswell Park Cancer Institute Corp · Buffalo, United States · NIH-9889667

  • A network for sharing data and resources in immuno-oncology

    This study is all about finding better ways to treat cancer using the body's immune system by working together with different experts to share information, which could lead to new treatments and help patients like you have more effective options.

    NIH research Roswell Park Cancer Institute Corp · Buffalo, United States · NIH-9625289

  • Targeting retrotransposons to help kids with hard-to-treat cancers like neuroblastoma

    Aims to repurpose safe antiviral drugs to block retrotransposons in children with relapsed or refractory neuroblastoma to improve outcomes.

    NIH research Roswell Park Cancer Institute Corp · Buffalo, United States · NIH-11535292

  • MedSupport: Helping families overcome barriers to kids' chemotherapy medicines

    This program offers extra support to parents of children with acute lymphoblastic leukemia to help them give home chemotherapy medicines more reliably.

    NIH research Roswell Park Cancer Institute Corp · Buffalo, United States · NIH-11508243

  • Innate immune cells and female lung cancer risk

    A study exploring how certain immune cells in the lungs may contribute to lung cancer in young women who don’t smoke.

    NIH research Roswell Park Cancer Institute Corp · Buffalo, United States · NIH-11455512

  • Effect of ONP filler materials on how fast nicotine is delivered

    This grant tests how different filler materials in oral nicotine pouches affect how quickly nicotine is released and absorbed in the mouth.

    NIH research Roswell Park Cancer Institute Corp · Buffalo, United States · NIH-11455485

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.